Rapid response to high cut-off haemodialysis and bortezomib therapy in a patient with acute renal failure and plasma cells dyscrasia

Li-Cavoli, Gioacchino; Tortorici, Calogera; Bono, Luisa; Ferrantelli, Angelo; Giammarresi, Carlo; Rotolo, Ugo; Di Bassiano, Francesco; Passantino, Rita.
Nefrología (Madr.) ; 34(5): 688-688, sept.-oct. 2014.
Artículo en Inglés | IBECS (España) | ID: ibc-130904

Documentos relacionados

  1. POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis.
  2. Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
  3. Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies.
  4. Reactive angioendotheliomatosis revealing a glomerulopathy secondary to a monoclonal gammopathy successfully treated with lenalidomide.
  5. Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
  6. Belimumab Is an IgG Lambda Therapeutic Monoclonal Antibody with the Potential to Cause Misdiagnosis of a Monoclonal Gammopathy.
  7. Non-crystalline light chain proximal tubulopathy, a morphologically protean entity.
  8. Cryoglobulinemic Vasculitis in Disguise: Cryofibrinogenemia as Variant of Monoclonal Gammopathy of Renal Significance.
  9. Monoclonal gammopathy of undetermined significance.
  10. Complement activation and cryoglobulinemia are common in monoclonal gammopathy of renal significance: Data from a case series.